Commonwealth Equity Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Commonwealth Equity Services’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Buy	10,734 +3,543	+49%	+$123K	﹤0.01%	3471
2026 Q1	$247K	Buy	7,191 +5	+0.1%	+$171	﹤0.01%	3812
2025 Q4	$237K	Buy	+7,186	New	+$224K	﹤0.01%	3841

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commonwealth Equity Services's FTXH Position: Q2 2026 in Review

Commonwealth Equity Services increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 49% in Q2 2026, buying an estimated $123K and bringing the position to 10,734 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Commonwealth Equity Services first reported a position in FTXH in Q4 2025 and has held it in 3 quarters since. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Commonwealth Equity Services held 10,734 shares of First Trust Nasdaq Pharmaceuticals ETF worth $410K as of Q2 2026.
Commonwealth Equity Services bought 3,543 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $123K.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3471 holding.
Commonwealth Equity Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.